High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
about
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsCS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activityRecent progress in structure-based anti-influenza drug designBackbone Structure of the Amantadine-Blocked Trans-Membrane Domain M2 Proton Channel from Influenza A VirusUnique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Drug resistance in influenza A virus: the epidemiology and management.Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systemsGenomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 HemagglutininsANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicWhy bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data.Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 seasonLaninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza AAdamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.Antiviral effect of methylated flavonol isorhamnetin against influenza.Stochastic model of an influenza epidemic with drug resistanceThe chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain.Ode to oseltamivir and amantadine?Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.Genetic strategy to prevent influenza virus infections in animalsUse of rapid tests and antiviral medications for influenza among primary care providers in the United StatesAntiviral and antibiotic prescribing for influenza in primary careThe origin and global emergence of adamantane resistant A/H3N2 influenza viruses.In vitro Anti-viral Activity of Psoraleae Semen Water Extract against Influenza A Viruses.Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model.Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.Influenza exerts continued pressure in an era of modern medicine.Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.Advancements in Host-Based Interventions for Influenza TreatmentOrally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesDisparities in influenza treatment among disabled Medicaid patients in Georgia
P2860
Q21142658-E5F32D57-F172-44ED-AF50-93180503A528Q24655526-0BF14902-8074-480D-AF5E-C4BCB186FDCBQ26863710-64078B6D-8F21-4F1A-9DB8-14A298B585C5Q27644223-861319DD-606E-4E00-BD0B-5A34893F9636Q30202859-FE117E6B-D132-4A1A-AE36-E4D161D85114Q30234600-1746C561-9B3C-4F55-B366-514380986EA7Q30374227-69EB03C3-DCE2-408A-818C-FDF14B8DE007Q30377815-3C85AAAF-5897-4DD3-80FB-11C572A8E771Q30382408-E32A3584-FFAD-48A2-A628-876A56A454E7Q30391963-9CB1D731-DE12-4B96-97F2-1B1AF11078E4Q30392944-ED81376D-A0C9-44A8-88C8-0043916D84FCQ30404586-9A0D482F-7E89-4EE0-AC2F-5772180CEEB9Q30415228-B599649B-B624-40DD-9F41-811FC87A2434Q30872106-9A227C7F-8B33-455D-A38E-350E7C5CD101Q33422252-54BDCD60-D541-4C0B-847D-F28EA3DEA294Q33529064-ADF348AA-FAD9-43A2-A7A8-1040063DE91BQ33676271-F4EC777D-3329-4701-A1EA-FDB8F8C038B4Q34023430-27B8822C-1873-4655-96F7-639DE7BB34ABQ35175284-1DCD25BE-A92B-49E0-98A0-C83AD1216360Q35217208-813AA292-9B4D-4CCF-9AD0-6D491EB940DAQ35644886-EDEE4EEA-6559-42E5-9207-282A5AFCBF21Q35881242-9CD509C4-687A-408C-8331-FF03E5808C30Q36171127-34EC8087-297D-46AF-BF49-2AE5E75F5A7EQ36432764-B08E24F2-EDF7-4CC3-AF83-90B69A4F3171Q36870919-964E7A6E-BE96-4CA6-A8FE-60A3794CFEC5Q37082747-CE203E4F-5EB2-4A20-A972-4A1C59DBCF36Q37087704-A0C2F509-322E-4657-85F7-7FC253D85117Q37136683-15928B03-D08F-48DB-BDFA-BB5A27342848Q37250829-D58211CF-7809-4FAA-9A34-B90FD70203E2Q37452496-13B815FE-084B-4BE5-8FB4-DFFC341EF345Q37463506-82863D14-2655-4143-9C99-090734D8929FQ40622883-D2239791-0A22-4A1D-A907-2A04D60897BEQ43080100-26EC902C-9B94-4AFC-BE1C-DE2C86A7B115Q45947329-EF9CB8A6-ECC9-4CF9-8B8D-8A905ABECBB6Q56996774-F62D23E1-397D-425D-9F23-B6B33AA5B7E7Q57095720-414CFB84-D809-49B1-9F2E-50F81C59DA1EQ57110044-A5639B1D-B543-4EF0-9C9B-946BB001F713
P2860
High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High levels of adamantane resi ...... tes, 2005-06 influenza season.
@ast
High levels of adamantane resi ...... tes, 2005-06 influenza season.
@en
type
label
High levels of adamantane resi ...... tes, 2005-06 influenza season.
@ast
High levels of adamantane resi ...... tes, 2005-06 influenza season.
@en
prefLabel
High levels of adamantane resi ...... tes, 2005-06 influenza season.
@ast
High levels of adamantane resi ...... tes, 2005-06 influenza season.
@en
P1476
High levels of adamantane resi ...... ates, 2005-06 influenza season
@en
P577
2006-01-01T00:00:00Z